Cited by 17,038Global Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionEconomic and Financial Impacts of Cancer

The DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.

Cancer statistics in China, 2015

Open access

Chen, Wanqing, Zheng, Rongshou, Baade, Peter D., Zhang, Siwei, Zeng, Hongmei, Bray, Freddie, Jemal, Ahmedin, Yu, Xue Qin, He, Jie·2016·CA: A Cancer Journal for Clinicians

DOI 10.3322/caac.21338

Open this paper in CoChat — free account Open PDF

Abstract

With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high‐quality data from an additional number of population‐based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population‐based cancer registries (2009‐2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015. Data from 22 registries were used for trend analyses (2000‐2011). The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death. Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death. Residents of rural areas had significantly higher age‐standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively). For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females. In contrast, the mortality rates since 2006 have decreased significantly for both males (−1.4% per year; P < .05) and females (−1.1% per year; P < .05). Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations. CA Cancer J Clin 2016;66:115–132. © 2016 American Cancer Society.

Integrity signals

Registry

Crossref · 10.3322/caac.21338

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Global cancer statistics
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Self-citation
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,858
Self-citation
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Self-citation
China statistical yearbook
中華人民共和国国家統計局 (1988) · Medical Entomology and Zoology · Cited by 12,443
Cancer statistics, 2015
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,854
Self-citation
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Cancer Incidence in Five Continents
Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990

Flagged first, then by citations

Show all 85 references

2 of the 85 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

National Cancer Center, Disease Prevention and Control Bureau, Ministry of Health, 2012, Chinese Cancer Registry Annual Report 2012
Ferlay J, 2005, Check and Conversion Programs for Cancer Registries (IARC/IACR Tools for Cancer Registries). IARC Technical Report No. 42
Chen Z, 2008, National Death Survey Report 2004–2005
2015, Will China make the great leap in tobacco control in 2015 [editorial]?, Lancet., 385, 2122
Kang LN, 2014, Cancer screening and prevention in China [serial online], Cancer Control 2014., 131

Sorted by citations

Cancer statistics in China and United States, 2022: profiles, trends, and determinants
Xia, C., Dong, X., Li, H., Cao, M., Sun, D., He, S., Yang, F., Yan, X., Zhang, S., Li, N., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002108 · Cited by 3,675
Self-citation
Nasopharyngeal carcinoma
Chen, Y., Chan, A. T. �., Le, Q., Blanchard, P., Sun, Y. H., & Ma, J. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30956-0 · Cited by 3,157
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
Cao, W., Chen, H., Yu, Y., Li, N., & Chen, W. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001474 · Cited by 2,886
Self-citation
Cancer incidence and mortality in China, 2022
Han, B., Zheng, R., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., & He, J. (2024) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.01.006 · Cited by 2,379
Self-citation
Global burden of primary liver cancer in 2020 and predictions to 2040
Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C. J., Vignat, J., Laversanne, M., McGlynn, K. A., & Soerjomataram, I. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.021 · Cited by 2,197
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Jing, X., Yang, F., Shao, C., Wei, K., Xie, M., Shen, H., & Shu, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1089-9 · Cited by 2,054
Epidemiology of Esophageal Squamous Cell Carcinoma
Abnet, C. C., Arnold, M., & Wei, W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.023 · Cited by 1,696
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Feng, R., Zong, Y., Cao, S., & Xu, R. (2019) · 癌症：英文版 · doi:10.1186/s40880-019-0368-6 · Cited by 1,646
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0422 · Cited by 1,589
Epidemiology and determinants of obesity in China
Pan, X., Wang, L., & Pan, A. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00045-0 · Cited by 1,587
Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries
Zeng, H., Chen, W., Zheng, R., Zhang, S., Ji, J. S., Zou, X., Xia, C., Sun, K., Yang, Z., Li, H., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30127-x · Cited by 1,558
Self-citation
Epidemiology of ovarian cancer: a review
Reid Brett, M., Reid Brett, M., Permuth, J. B., Sellers Thomas, A., Permuth, J. B., & Sellers Thomas, A. (2017) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2016.0084 · Cited by 1,604
Cancer incidence and mortality in China, 2016
Zheng, R., Sun, K., Han, B., Li, L., Chen, R., Wang, S., Li, L., Zeng, H., He, J., Wei, W., et al. (2022) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2022.02.002 · Cited by 1,516
“More details about those registries have been reported in a previous study 1 .”
Self-citation
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,643
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
Ren, Z., Xu, J., Bai, Y., Xu, A., Cang, S., Du, C., Li, Q., Lu, Y., Chen, Y., Guo, Y., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00252-7 · Cited by 1,124
Oesophageal cancer
Smyth, E. C., Lagergren, J., Fitzgerald, R. C., Lordick, F., Shah, M. A., Lagergren, P., & Cunningham, D. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.48 · Cited by 1,077
Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020
Qiu, H., Cao, S., & Xu, R. (2021) · 癌症：英文版 · doi:10.1002/cac2.12197 · Cited by 1,032
Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor−κB, and Up-regulating Expression of MicroRNA-21
Yang, Y. P., Weng, W., Peng, J., Hong, L., Yang, L., Toiyama, Y., Gao, R., Liu, M., Yin, M., Pan, C., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.11.018 · Cited by 1,037
Cancer incidence and mortality in China, 2014
Chen, W., Sun, K., Zheng, R., Zeng, H., Zhang, S., Xia, C., Yang, Z., He, L., Zou, X., & He, J. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.01.01 · Cited by 1,019
Self-citation
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
Yang, H., Liu, H., Chen, Y., Zhu, C., Fang, W., Yu, Z., Mao, W., Xiang, J., Han, Y., Chen, Z., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.1483 · Cited by 1,003
Physical activity, exercise, and chronic diseases: A brief review
Anderson, E., & Durstine, J. L. (2019) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2019.08.006 · Cited by 1,162
The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention
Liu, Z., Jiang, Y., Yuan, H., Fang, Q., Cai, N., Suo, C., Li, J., Zhang, T., & Chen, X. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.001 · Cited by 826
Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
Ren, Z., Li, A., Jiang, J., Zhou, L., Yu, Z., Lu, H., Xie, H., Chen, X., Shao, L., Zhang, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315084 · Cited by 782
Liquid biopsy in cancer: current status, challenges and future prospects
Ma, L., Guo, H., Zhao, Y., Liu, Z., Wang, C., Bu, J., Sun, T., & Wei, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02021-w · Cited by 820
Role of pyroptosis in inflammation and cancer
Xiang, W. D., Xie, F., Zhou, X., Wu, Y., Yan, H., Liu, T., Huang, J. S., Wang, F., Zhou, F., & Zhang, L. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00905-x · Cited by 728
A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks
Fang, E. F., Xie, C., Schenkel, J. A., Wu, C., Long, Q., Cui, H., Aman, Y., Frank, J., Liao, J., Zou, H., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101174 · Cited by 717
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Zhou, J., Sun, H., Wang, Z., Cong, W., Wang, J., Zeng, M., Yang, J.-M., Bie, P., Liu, L.-X., Wen, T., et al. (2018) · Liver Cancer · doi:10.1159/000488035 · Cited by 649
Self-citation
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Du, D., Liu, C., Qin, M., Zhang, X., Xi, T., Yuan, S., Hao, H., & Xiong, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.019 · Cited by 665
The role of TGF-β/SMAD4 signaling in cancer
Zhao, M., Mishra, L., & Deng, C.-X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.23230 · Cited by 631
The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017
Etemadi, A., Safiri, S., Sepanlou, S. G., Ikuta, K. S., Bisignano, C., Shakeri, R., Amani, M., Fitzmaurice, C., Nixon, M. R., Abbasi, N., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30328-0 · Cited by 643
Global trends and predictions in hepatocellular carcinoma mortality
Bertuccio, P., Turati, F., Carioli, G., Rodriguez, T., Vecchia, C. L., Malvezzi, M., & Negri, E. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.011 · Cited by 635
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
Chen, X., Gole, J., Gore, A., He, Q., Lü, M., Min, J., Yuan, Z., Yang, X., Jiang, Y., Zhang, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17316-z · Cited by 649
Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
Zheng, P., Chen, L., Yuan, X., Luo, Q., Liu, Y., Xie, G., Ma, Y., & Shen, L. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0528-y · Cited by 637
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer
Han, B., Li, K., Wang, Q., Zhang, L., Shi, J., Wang, Z., Cheng, Y., He, J., Shi, Y., Zhao, Y., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.3039 · Cited by 617
Self-citation
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Jiang, T., Mao, Y. Q., Ma, W., Mao, Q., You, Y., Yang, X., Jiang, C., Kang, C., Li, X., Chen, L., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.024 · Cited by 609
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
Qin, S., Ren, Z., Meng, Z., Chen, Z., Chai, X., Xiong, J., Bai, Y., Yang, L., Zhu, H., Fang, W. J., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30011-5 · Cited by 604
Pancreatic cancer: A review of epidemiology, trend, and risk factors
Hu, J.-X., Zhao, C., Chen, W.-B., Liu, Q., Li, Q.-W., Lin, Y., & Gao, F. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i27.4298 · Cited by 643
Self-citation
Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐Analysis
Zhou, F., Zhou, J., Wang, W., Zhang, X., Ji, Y., Zhang, P., She, Z., Zhu, L., Cai, J., & Li, H. (2019) · Hepatology · doi:10.1002/hep.30702 · Cited by 589
The Intestinal Microbiota and Colorectal Cancer
Cheng, Y., Ling, Z., & Li, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.615056 · Cited by 609
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 641
Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis
Zhang, H., Deng, T., Liu, R., Bai, M., Zhou, L., Wang, X., Li, S., Wang, X., Yang, H., Li, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15016 · Cited by 568
Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation Sequencing
Jin, X., Chen, Y., Chen, H., Fei, S., Chen, D., Cai, X., Liu, L., Lin, B., Su, H., Zhao, L., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0577 · Cited by 560
Global liver disease burdens and research trends: Analysis from a Chinese perspective
Xiao, J., Wang, F., Wong, N.-K., He, J., Rui, Z., Sun, R., Xu, Y., Liu, Y., Li, W., Koike, K., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.004 · Cited by 568
Self-citation
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China
Xu, X.-F., Xing, H., Han, J., Li, Z.-L., Lau, W.-Y., Zhou, Y.-H., Gu, W.-M., Wang, H., Chen, T.-H., Zeng, Y.-Y., et al. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2018.4334 · Cited by 532
Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
Lü, Y., Xue, J., Deng, T., Zhou, X., Yu, K., Deng, L., Huang, M., Yi, X., Liang, M., Wang, Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0840-5 · Cited by 553
Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA
Wang, M., Mao, C., Ouyang, L., Liu, Y., Lai, W., Liu, N., Shi, Y., Chen, L., Xiao, D., Yu, F., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0304-y · Cited by 530
National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance data
Qi, J., Li, M., Wang, L., Hu, Y., Liu, W. Y., Long, Z., Zhou, Z., Yin, P., & Zhou, M. (2023) · The Lancet Public Health · doi:10.1016/s2468-2667(23)00211-6 · Cited by 534
DNA Damage, Mutagenesis and Cancer
Basu, A. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040970 · Cited by 556
Cancer registration in China and its role in cancer prevention and control
Wei, W., Zeng, H., Zheng, R., Zhang, S., An, L., Chen, R., Wang, S., Sun, K., Matsuda, T., Bray, F., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30073-5 · Cited by 497
Self-citation
Cervical cancer: Epidemiology, risk factors and screening
Zhang, S., Xu, H., Zhang, L., & Qiao, Y. (2020) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2020.06.05 · Cited by 565
Self-citation
Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells
Yu, J., Li, S., Qi, J., Chen, Z., Wu, Y., Guo, J., Wang, K., Sun, X., & Zheng, J. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1441-4 · Cited by 481
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Zhou, J., Sun, H., Wang, Z., Cong, W., Zeng, M., Zhou, W., Bie, P., Liu, L., Wen, T., Kuang, M., et al. (2023) · Liver Cancer · doi:10.1159/000530495 · Cited by 505
Self-citation
Epidemiology of lung cancer in China
Cao, M., & Chen, W. (2018) · Thoracic Cancer · doi:10.1111/1759-7714.12916 · Cited by 471
Self-citation
Cancer incidence and mortality in China, 2013.
Chen, W.-Q., Zheng, R.-S., Zhang, S.-W., Zeng, H., Xia, C., Zuo, T.-T., Yang, Z.-X., Zou, X., & He, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.024 · Cited by 403
Self-citation
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
Wang, F., Wei, X., Wang, F., Xu, N., Shen, L., Dai, G., Yuan, X., Chen, Y., Yang, S., Shi, J., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz197 · Cited by 460
Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation
Zhang, C., Li, C., Wang, Y., Xu, L., He, X., Zeng, Q., Zeng, C., Mai, F., Hu, B., & Ouyang, D. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01515-1 · Cited by 447
Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013
Islami, F., Chen, W., Yu, X. Q., Lortet‐Tieulent, J., Zheng, R., Flanders, W. D., Xia, C., Thun, M. J., Gapstur, S. M., Ezzati, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx342 · Cited by 439
Self-citation
Cancer burden of major cancers in China: A need for sustainable actions
Cao, M., He, L., Sun, D., & Chen, W. (2020) · 癌症：英文版 · doi:10.1002/cac2.12025 · Cited by 439
Self-citation
Clinical practice guidelines for the management of adult diffuse gliomas
Jiang, T., Nam, D., Ram, Z., Poon, W. S., Wang, J., Boldbaatar, D., Mao, Y. Q., Ma, W., Mao, Q., You, Y., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.050 · Cited by 434
Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study
Li, X., Zhang, S., Zhang, Q., Wei, X., Pan, Y., Zhao, J., Xin, X., Qin, C., Wang, X., Li, J., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30762-9 · Cited by 439
Self-citation
circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1
Cheng, Z., Yu, C., Cui, S., Wang, H., Jin, H., Wang, C., Li, B., Qin, M., Yang, C. G., He, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11162-4 · Cited by 419
Self-citation
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
Tang, L., Chen, Y., Chen, C., Chen, M., Chen, N., Chen, X., Du, X., Fang, W., Feng, M., Gao, J., et al. (2021) · 癌症：英文版 · doi:10.1002/cac2.12218 · Cited by 424
HCAR1/MCT1 Regulates Tumor Ferroptosis through the Lactate-Mediated AMPK-SCD1 Activity and Its Therapeutic Implications
Zhao, Y., Li, M., Yao, X., Yang, F., Lin, Z., Li, Z., Cai, K., Zhao, Y., & Luo, Z. Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108487 · Cited by 420
Targeting hypoxic tumor microenvironment in pancreatic cancer
Tao, J., Yang, G., Zhou, W., Qiu, J., Chen, G., Luo, W., Zhao, F., You, L., Zheng, L., Zhang, T., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01030-w · Cited by 431
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer: The FRESCO Randomized Clinical Trial
Li, J., Qin, S., Xu, R.-H., Shen, L., Xu, J., Bai, Y., Yang, L., Deng, Y., Chen, Z.-D., Zhong, H., et al. (2018) · JAMA · doi:10.1001/jama.2018.7855 · Cited by 425
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Qin, C., Yang, G., Yang, J., Ren, B., Wang, H., Chen, G., Zhao, F., You, L., Wang, W., & Zhao, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01169-7 · Cited by 433
Epidemiology of prostate cancer in Asian countries
Kimura, T., & Egawa, S. (2018) · International Journal of Urology · doi:10.1111/iju.13593 · Cited by 413
A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis
Wang, Y., Yang, L., Chen, T., Liu, X., Guo, Y., Zhu, Q., Tong, X., Yang, W., Xu, Q., Huang, D., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0957-7 · Cited by 408
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
Qin, S., Bi, F., Gu, S., Bai, Y., Chen, Z., Wang, Z., Ying, J., Lu, Y., Meng, Z., Pan, H., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00163 · Cited by 412
Clinically applicable histopathological diagnosis system for gastric cancer detection using deep learning
Song, Z., Zou, S., Zhou, W., Huang, Y., Shao, L., Yuan, J., Gou, X., Jin, W., Wang, Z., Chen, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18147-8 · Cited by 444
Molecular mechanisms for tumour resistance to chemotherapy
Pan, S., Li, Z., He, Z., Qiu, J., & Zhou, S. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12581 · Cited by 415
PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions
Xia, L., Liu, Y., & Wang, Y. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-io-s1-s05 · Cited by 397
Cancer incidence and mortality in China, 2015
Zhang, S., Sun, K., Zheng, R., Zeng, H., Wang, S., Chen, R., Wei, W., & He, J. (2020) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2020.12.001 · Cited by 396
Self-citation
Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials
Shi, D., Shi, Y., Kaseb, A. O., Qi, X., Zhang, Y., Chi, J., Lü, Q., Gao, H., Jiang, H., Wang, H., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3259 · Cited by 396
Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression
Zhang, J., Bai, R., Li, M., Ye, H., Wu, C. H., Wang, C., Li, S., Tan, L., Mai, D., Li, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09712-x · Cited by 381
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Ye, Q., Ling, S., Zheng, S., & Xu, X. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1043-x · Cited by 389
Participation and yield of a population-based colorectal cancer screening programme in China
Chen, H., Li, N., Ren, J., Feng, X., Lyu, Z., Wei, L., Li, X., Guo, L., Zheng, Z., Zou, S., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-317124 · Cited by 378
Self-citation
Dissecting Esophageal Squamous-Cell Carcinoma Ecosystem by Single-Cell Transcriptomic Analysis
Zhang, X., Peng, L., Luo, Y., Zhang, S., Pu, Y., Chen, Y., Guo, W., Yao, J., Shao, M., Fan, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-021-25539-x · Cited by 385
Self-citation
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
Wu, Y.-L., Lu, S., Cheng, Y., Zhou, C., Wang, J., Mok, T., Zhang, L., Tu, H.-Y., Wu, L., Feng, J., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.01.006 · Cited by 357
Systemic immune‐inflammation index, neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio can predict clinical outcomes in patients with metastatic non‐small‐cell lung cancer treated with nivolumab
Liu, J., Li, S., Zhang, S., Liu, Y., Ma, L., Zhu, J., Xin, Y., Wang, Y., Yang, C., & Cheng, Y. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22964 · Cited by 364
Self-citation
Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
Yang, H., Liu, H., Chen, Y., Zhu, C., Fang, W., Yu, Z., Mao, W., Xiang, J., Han, Y., Chen, Z., et al. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2021.2373 · Cited by 378
CD155T/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer
He, W., Zhang, H., Han, F., Chen, X., Lin, R., Wang, W., Qiu, H., Zhuang, Z., Liao, Q., Zhang, W., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0381 · Cited by 359
Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer
Bao, Y., Wang, L., Shi, L., Yun, F., Liu, X., Chen, Y., Chen, C., Ren, Y., & Jia, Y. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0162-0 · Cited by 355
Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities
Kashyap, B. K., Singh, V. V., Solanki, M. K., Kumar, A. K. S., Ruokolainen, J., & Kesari, K. K. (2023) · ACS Omega · doi:10.1021/acsomega.2c07840 · Cited by 367
The challenge of screening for early gastric cancer in China
Zong, L., Abe, M., Seto, Y., & Ji, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32226-7 · Cited by 350
Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis
Li, J., Li, Z., Jiang, P., Peng, M., Zhang, X., Chen, K., Liu, H., Bi, H., Liu, X., & Li, X. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0822-3 · Cited by 351
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer
Wang, L., Tong, X., Zhou, Z., Wang, S., Lei, Z., Zhang, T., Liu, Z., Zeng, Y., Li, C., Zhao, J., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0889-7 · Cited by 351
Liver cancer incidence and mortality in China: Temporal trends and projections to 2030
Zheng, R., Qu, C., Zhang, S., Zeng, H., Sun, K., Gu, X., Xia, C., Yang, Z., Li, H., Wei, W., et al. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.06.01 · Cited by 343
Self-citation
Circular RNA-ITCH Suppresses Lung Cancer Proliferation via Inhibiting the Wnt/β-Catenin Pathway
Wan, L., Zhang, L., Fan, K., Cheng, Z., Sun, Q., & Wang, J. (2016) · BioMed Research International · doi:10.1155/2016/1579490 · Cited by 343
The precision prevention and therapy of HPV ‐related cervical cancer: new concepts and clinical implications
Hu, Z., & Ma, D. (2018) · Cancer Medicine · doi:10.1002/cam4.1501 · Cited by 353
Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p
Liu, Z., Zhou, Y., Liang, G., Ling, Y., Tan, W., Tan, L., Andrews, R., Zhong, W., Zhang, X., Song, E., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1287-1 · Cited by 336
Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E
Zheng, P., Luo, Q., Wang, W., Li, J., Wang, T., Wang, P., Chen, L., Zhang, P., Chen, H., Liu, Y., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0465-5 · Cited by 381
Efficient Semi-supervised Gross Target Volume of Nasopharyngeal Carcinoma Segmentation via Uncertainty Rectified Pyramid Consistency
Luo, X., Liao, W., Chen, J., Song, T., Chen, Y., Zhang, S., Chen, N., Wang, G., & Zhang, S. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-87196-3_30 · Cited by 335
Self-citation
Breast cancer heterogeneity and its implication in personalized precision therapy
Guo, L., Kong, D., Liu, J., Zhan, L., Luo, L., Zheng, W., Zheng, Q., Chen, C., & Sun, S. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00363-1 · Cited by 370
“For instance, in situ recurrence, distant metastasis, and many clinical problems in breast cancer treatment arise from the heterogeneity [1, 6–8].”
Background
Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer
YiRen, H., Yu, Y., Sunwu, Y., Li, K., Xiaochun, T., Senrui, C., Chen, E., Lin, X., & Yanfan, C. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0743-3 · Cited by 334
Tumor‐Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel‐Enhanced Immunotherapy with Polarization toward M1‐Type Macrophages on Triple Negative Breast Cancers
Chen, L., Zhou, L., Wang, C., Han, Y., Lu, Y., Liu, J., Hu, X., Yao, T., Lin, Y., Liang, S., et al. (2019) · Advanced Materials · doi:10.1002/adma.201904997 · Cited by 337
Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer
Ye, L., Zhang, T., Kang, Z., Guo, G., Sun, Y., Lin, K., Huang, Q., Shi, X., Ni, Z., Ding, N., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02368 · Cited by 335
Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression
Pan, L., Liang, W., Fu, M., Huang, Z., Li, X., Zhang, W., Zhang, P., Qian, H., Jiang, P., Xu, W., et al. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2361-2 · Cited by 330
Epidemiology of lung cancer and lung cancer screening programs in China and the United States
Yang, D., Liu, Y., Bai, C., Wang, X., & Powell, C. A. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.009 · Cited by 332
Global trends in esophageal cancer
Malhotra, G. K., Yanala, U., Ravipati, A., Follet, M., Vijayakumar, M., & Are, C. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24592 · Cited by 329

Authors: Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J.
Affiliations: Deputy Director, National Office for Cancer Prevention and Control National Cancer Center Beijing China
Associate Researcher, National Office for Cancer Prevention and Control National Cancer Center Beijing China
Cancer Council Queensland (AU)
Associate Professor, National Office for Cancer Prevention and Control National Cancer Center Beijing China
Centre international de recherche sur le cancer (FR)
American Cancer Society (US)
The University of Sydney (AU)
Director National Cancer Center Beijing China.
Corresponding author: Chen, Wanqing
ORCID: Chen, Wanqing
Zheng, Rongshou
Baade, Peter D.
Zhang, Siwei
Zeng, Hongmei
Bray, Freddie
Jemal, Ahmedin
Yu, Xue Qin
He, Jie
Venue: CA: A Cancer Journal for Clinicians
Publisher: Wiley
Published: 2016-01-25
Volume: 66
Issue: 2
Pages: 115-132
ISSN: 0007-9235 (ISSN-L)
1542-4863
DOI: 10.3322/caac.21338
OpenAlex: W2272984102
Cited by: 17,038
References: 85
Citations by year: 2026: 142 · 2025: 461 · 2024: 1006 · 2023: 1271 · 2022: 1900 · 2021: 2470 · 2020: 2710 · 2019: 2630 · 2018: 2296 · 2017: 1648 · 2016: 486
FWCI: 1269.33
Type: journal article
Language: en
Open access: gold
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: CA A Cancer Journal for Clinicians (publishedVersion)
PubMed (publishedVersion)
Griffith Research Online (submittedVersion, other-oa)
The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
Funders: National Health and Family Planning Commission of China
Ministry of Science and Technology (2014FY121100)
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
Keywords: cancer incidence, cancer mortality, cancer burden estimation, lung cancer, gastric cancer, esophageal cancer, liver cancer, urban-rural differences, cancer incidence trends, population-based cancer registry, cancer prevention, China
MeSH terms: Adult, Aged, China, Esophageal Neoplasms, Female, Humans, Liver Neoplasms, Lung Neoplasms, Male, Middle Aged, Neoplasms, Risk Factors, Rural Population, Stomach Neoplasms, Urban Population, Incidence, Prevalence, Survival Rate, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cancer statistics in China, 2015

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks